Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-11

Clinical Trial Update: The Study of Ginkgo Leaf Dropping Pills and Huperzine a Injection Combined with Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a combination therapy of Ginkgo Leaf Dropping Pills and Huperzine A injection with median nerve electrical stimulation for cog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ginkgo Leaf Dropping Pills (Ginkgo biloba extract)
  • Huperzine A injection (Huperzine A)

Snippet

Sponsor: Wanbangde Pharmaceutical Group Co., LTD | Conditions: Cognitive Impairment After Brain Injury | Phase 4 | Status: RECRUITING